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ABSTRACT
Introduction: Immunoglobulin A vasculitis (formerly known as Henoch Schonlein Purpura) 
is the most common pediatric vasculitis, which occurs typically at the age of 3-15 years. 
Mononucleosis, group A Streptococcus, Campylobacter and Mycoplasma are some of the common 
infectious causes of immunoglobulin A vasculitis. Immunoglobulin A vasculitis is a clinically 
diagnosed disease. Most common clinical features include nonthrombocytopenic nonpruritic 
palpable purpura, gastrointestinal involvement, arthritis or arthralgia and renal involvement. 
Biopsy of skin and/or gastrointestinal lesions confirm the diagnosis, although this is not 
necessary. Immunoglobulin A vasculitis is a self-limiting disease, which resolves spontaneously. 
Steroids can be used for the treatment of moderate to severe disease and for the prevention of 
renal complications. Prognosis relies upon various factors among which involvement of kidneys 
dictates poor prognosis and requires close follow up. Case Presentation: We are presenting 
a case of immunoglobulin A vasculitis in a 39-year-old German male following influenza 
virus infection. The infectious agent that cause immunoglobulin A vasculitis in our patient 
was Influenza A virus. Biopsy of the skin lesion confirmed the diagnosis of immunoglobulin A 
vasculitis in our patient. The patient responded to steroids and his skin and GI findings resolved. 
Conclusion: Our case report adds to the literature of medicine by describing influenza virus as 
a cause of immunoglobulin A vasculitis in young adult patients. Considering immunoglobulin 
A vasculitis after influenza and outside of the typical age of 3-15 years, can help to make earlier 
diagnosis and prevent complications.
INTRODUCTION
Immunoglobulin A (IgA) vasculitis is a self-limiting, auto-
immune, systemic, most commonly pediatric, small vessel 
vasculitis (1,2,5). The classic age range of IgA vasculitis 
occurrence is 3 to 15 years (8). This disease is uncommon 
in adults. Precipitating factors of IgA vasculitis include in-
fections, medications, vaccinations, insect bites, and food 
allergies. The common infectious causes that are responsi-
ble for causing IgA vasculitis include Group A streptococcal 
infection, Campylobacter enteritis and Mycoplasma infec-
tion (8,11). This report presents a case of a 39-year-old male 
who developed classic features of IgA vasculitis10 days after 
being diagnosed with influenza A virus infection.
CASE PRESENTATION
A 39 year old German male came to the clinic with history 
of high fever, chills, headache, cough, back pain, and runny 
nose for 3 days. He was diagnosed with influenza A virus 
infection on rapid influenza test and was prescribed Tamiflu 
for 5 days. He came back to the clinic 10 days later with a 
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rash, which he noticed on his legs while travelling for work. 
The rash was nonpruritic, non-painful, and purpuric. It pro-
gressed from his bilateral legs and inner thighs to his abdo-
men, back, chest, and face. He was referred to a dermatolo-
gist who performed a skin biopsy. Pathology confirmed the 
diagnosis of IgA vasculitis. Four days later, he returned with 
severe worsening abdominal pain, progressive rash on his 
thighs, legs, back, and arms. He also complained of arthral-
gia of bilateral knees and elbows. Abdominal pain was ep-
isodic, located in the epigastrium, 8/10 in intensity, colicky 
in nature, non-radiating, and had no identified aggravating or 
relieving factors. Each episode lasted for a few minutes. He 
was referred to emergency room (ER) where he was started 
on 20 mg prednisone and discharged. Six days later, he de-
veloped nausea, diarrhea, hematemesis and severe abdomi-
nal pain. Review of the systems was normal except above 
mentioned problems. Hypertension, fatty liver disease and, 
obesity are his significant comorbidities. His past medical 
history includes a transient ischemic attack (TIA) 2 years 
ago. He is allergic to bee stings. His family history includes 
coronary artery disease and type 2 diabetes mellitus (DM) in 
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his father. Physical exam showed diffuse palpable purpura 
of the legs, thighs, back, arms and face (Figure 1 a-d). His 
abdomen was moderately tender to palpation. There was no 
redness, warmth, or swelling of his knee and ankle joints.
INVESTIGATION
His laboratory tests include:
• Complete blood count (CBC), White blood cells 
(WBCs): 21.9 X 1000/ul; Hemoglobin 18g/dl; absolute 
neutrophils 15.8 X 1000/ul; absolute lymphocytes 4.4 
X 1000/ul; absolute monocytes 1.5 X 1000/ul; platelets 
416 X 1000/ul
• Urinalysis was normal with no hematuria or proteinuria
• Urea nitrogen: 18 mg/dl
• Creatinine: 0.72 mg/dl
• Erythrocyte sedimentation rate (ESR): 6mm/hr
• C-reactive protein (CRP): 5.94 mg/dl
• Hepatitis A Antibody: non-reactive
• Hepatitis B surface antigen (HbsAg): non-reactive
• IgA Total Serum: 304 mg/dl
• IgE Total Serum: 79.5 mg/dl
• IgG Total Serum: 891 mg/dl
• IgM Total Serum: 51mg/dl
• Skin biopsy was taken from right inner thigh and showed 
deposition of IgA, C3 and fibrinogen in vessels.
• Endoscopy showed 5 cm long, dusky appearing, local-
ized hemorrhagic and edematous friable circumferential 
mucosa without active bleeding but with bloody exu-
date in the second part of duodenum. (Figure 2). Follow 
up endoscopy 2 months after starting steroid therapy 
showed normal duodenal mucosa having no evidence of 
inflammation or ulceration.
• Duodenal biopsy showed ulceration and fibrinous exu-
date
• Computed tomography (CT) of the abdomen showed 
abnormal thickening of cecum and terminal ileum 
with surrounding inflammatory changes as well as 
thickening of adjacent distal duodenum and proximal 
jejunum.
TREATMENT
Patient was started on prednisone 20 mg which was in-
creased to 60 mg on development of severe abdominal pain, 
hematemesis, nausea, and diarrhea. He was also prescribed 
clobetasol for the skin rash.
OUTCOME AND FOLLOW UP
The patient’s symptoms improved with prednisone. Early 
diagnosis and treatment prevented renal complications. He 
is now completing a slow prednisone taper and is doing very 
Figure 2. Endoscopic findings: Hemorrhagic and edematous mucosa of second part of duodenum
Figure 1. (a) Cutaneous lesions on lower extremities: Palpable purpura on left lower thigh and popliteal region, (b) Skin lesions on lower 
extremities: Palpable purpura on right leg, (c) Cutaneous lesions on abdomen: Scattered palpable purpura around umbilicus, left abdominal 
quadrant and hypogastrium, (d) Skin lesions on right ankle and foot: Multiple scattered palpable purpura on right ankle and foot
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well. He has had no subsequent abdominal pain and no new 
rash since his last visit to the ER.
DISCUSSION
IgA vasculitis is a systemic, autoimmune, small vessel vas-
culitis, which commonly involves the vessels of the skin, 
joints, gastrointestinal tract, and kidneys. (1) It is most com-
mon in pediatric populations with 90% of IgA vasculitis cas-
es occurring before the age of 10 years old (10). However, 
our patient developed IgA vasculitis at the age of 39, which 
is noteworthy. IgA vasculitis can be considered in the differ-
ential diagnosis of patients outside of typical age range and 
timely treatment should be provided.
Statistically, IgA vasculitis is twice as common in males 
as females and occur predominantly in winter and spring. 
The gender of our patient is male and he developed this dis-
ease in winter season. (1, 4, 10). Globally, the incidence of 
IgA vasculitis is highest among Asians. In the United States, 
Caucasians most commonly present with this disease. (19). 
Our patient was Caucasian which is consistent with the typi-
cal presentation of IgA vasculitis.
IgA vasculitis is considered a multifactorial disease with 
genetic, environmental and immunologic components. In-
fections (viral and bacterial), vaccination (typhoid, cholera, 
measles and yellow fever), drugs (antibiotics, non-steroidal 
anti–inflammatory drugs (NSAIDS) and angiotensin recep-
tor blockers (ARBS), insect bites and certain foods are the 
precipitating factors. The common infectious causes of IgA 
vasculitis are group A streptococcus infection, Mycoplasma 
infection, Campylobacter enteritis, Parvovirus, and Adeno-
virus (8, 11). IgA vasculitis in our patient followed influenza 
virus infection which is a very rare precipitating factor of 
IgA vasculitis. Two published case reports from China and 
Rome also presented influenza as a precipitating factor of 
IgA vasculitis. Chan Won Park and colleagues presented a 
case of IgA vasculitis in China in 2014. They reported IgA 
vasculitis in 4 years old girl with GI and renal manifestation 
of IgA vasculitis without skin involvement (3). However, our 
patient was much older and presented with typical clinical 
findings of IgA vasculitis. We confirmed the diagnosis with 
a skin biopsy.
Another report was published by Rocco Urso in Italy in 
2009. In that report, a 23-year-old Caucasian woman devel-
oped IgA vasculitis following H1N1 infection (7). The case 
presented with typical findings of IgA vasculitis. Our patient 
was different from their patient as our patient was a 39 years 
old male who developed typical signs and symptoms of IgA 
vasculitis following influenza A virus infection confirmed on 
rapid influenza testing. Moreover, we confirmed IgA vascu-
litis by skin biopsy.
Rashes occur in 95-100% of cases (11). The common 
skin manifestation includes nonthrombocytopenic nonpru-
ritic palpable purpura which occurs mostly in dependent 
parts of the body such as buttocks and lower extremities. 
Skin lesions can progress to upper parts of the body. Our 
patient presented with typical skin rashes of IgA vasculitis. 
Rashes appeared in both legs and thighs first and after few 
days the skin lesions spread to the back, arms, and face.
Gastrointestinal symptoms occur in 70 % of cases. Col-
icky abdominal pain is the most common gastrointestinal 
manifestation (8). Patients can also develop nausea, vomit-
ing, melena, and hematochezia. Mesenteric vasculitis is the 
cause of the GI symptoms. Abdominal pain in our patient 
developed one day after developing rashes and it occurred 
with hematemesis, nausea, and diarrhea.
60- 84% of IgA vasculitis patients develop joint pain. 
Knee and ankle joints are the most commonly involved (13). 
Our patient developed arthralgia in bilateral knees and ankles.
In IgA vasculitis, kidneys are affected days to months 
after skin manifestations. 20-50% of patients have renal in-
volvement and this plays a very important role in the prog-
nosis of IgA vasculitis (1). It is the most common cause of 
morbidity and mortality (11). Renal compromise with IgA 
vasculitis is more common in adults. Microscopic or gross 
hematuria are the most common renal findings. Patients can 
also develop proteinuria (1). Luckily, our patient did not de-
velop any of the abnormal renal findings but he is still under 
surveillance for renal disease.
IgA vasculitis is generally a clinical diagnosis. Blood 
tests may reveal normal or elevated platelets, mild leuko-
cytosis, elevated IgA levels. In about 50% of cases ESR and 
CRP are elevated. (8) Skin or kidney biopsies can be done in 
unusual cases to confirm the diagnosis. Skin biopsy usually 
shows leukocytoclastic vasculitis with IgA deposition.
IgA vasculitis resolves spontaneously in 89% of adults. 
Analgesics are usually provided for abdominal and joint 
pain (15). Oral or intravenous (IV) steroids should be provid-
ed to the patient with moderate to severe diseases. (14). Ste-
roid therapy early in the disease process decreases the dura-
tion of symptoms, prevents recurrence and benefits kidneys. 
Our patient was started on steroids early in his disease pro-
cess which, may have prevented renal complication and de-
creased the disease duration. His blood urea nitrogen (BUN), 
creatinine, and urinalysis are all within normal limits.
Previous case reports have described the development of 
IgA vasculitis after influenza virus infection and influenza 
vaccination, which divert our attention towards conducting 
research on the pathogenesis of IgA vasculitis after influ-
enza. (6, 20, 21, 22) Additionally, more research is needed 
to determine the type or strand of influenza virus that may 
cause IgA vasculitis. In our case, IgA vasculitis followed in-
fluenza A virus infection
PROGNOSIS
Prognosis of IgA vasculitis is good with a 95% survival rate 
after 5 years. (1) Short term prognosis depends upon gastro-
intestinal (GI) involvement and long term prognosis depends 
upon renal involvement. (12)
Older age at diagnosis (age more than 8 years), renal 
abnormalities (high creatinine, proteinuria, hematuria), and 
rashes above waist line are considered poor prognostic fac-
tors. (1, 16, 17, 18) The older age of our patient and rashes 
above waist line were two negative prognostic factors in our 
patient. However, early diagnosis and treatment may have 
prevented renal complications in our patient.
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CONCLUSION
Non palpable purpura in middle aged patients after influenza 
should prompt consideration of IgA vasculitis as a potential 
diagnosis. In this way complications and multi organ failure 
can be avoided. Early and proper diagnosis would also help 
avoid unnecessary treatment.
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